(Total Views: 220)
Posted On: 05/09/2020 10:56:30 AM
Post# of 27260
Might Enzymes Help Blood Clotting Associated With COVID-19?
STORY AT-A-GLANCE
Aside from sepsis — which in one study was present in 59% of COVID-19 patients and 100% of those who died — blood clots also appear to be common in patients with severe COVID-19 disease
Abnormal coagulation is associated with poor prognosis in patients with COVID-19. According to one case report, 71.4% of patients who died of COVID-19 met the criteria for disseminated intravascular coagulation (DIC) while only 0.6% of patients who survived met that criteria
DIC refers to a systemic disorder that affects blood coagulation and can result in organ dysfunction and death. Prothrombotic DIC causes persistent blood clots. Sepsis is one of the most common causes of DIC
Doctors are divided when it comes to treatment of DIC. Some believe early administration of blood thinners is advisable, while other data suggest they don’t improve outcomes
Holistic prophylactic alternatives that might be beneficial against blood clots include proteolytic enzymes such as lumbrokinase, nattokinase and serrapeptase, all of which act as natural anticoagulants by breaking down the fibrin that forms the blood clot
https://articles.mercola.com/sites/articles/a...=868247236
STORY AT-A-GLANCE
Aside from sepsis — which in one study was present in 59% of COVID-19 patients and 100% of those who died — blood clots also appear to be common in patients with severe COVID-19 disease
Abnormal coagulation is associated with poor prognosis in patients with COVID-19. According to one case report, 71.4% of patients who died of COVID-19 met the criteria for disseminated intravascular coagulation (DIC) while only 0.6% of patients who survived met that criteria
DIC refers to a systemic disorder that affects blood coagulation and can result in organ dysfunction and death. Prothrombotic DIC causes persistent blood clots. Sepsis is one of the most common causes of DIC
Doctors are divided when it comes to treatment of DIC. Some believe early administration of blood thinners is advisable, while other data suggest they don’t improve outcomes
Holistic prophylactic alternatives that might be beneficial against blood clots include proteolytic enzymes such as lumbrokinase, nattokinase and serrapeptase, all of which act as natural anticoagulants by breaking down the fibrin that forms the blood clot
https://articles.mercola.com/sites/articles/a...=868247236
(0)
(0)
